Becerra Says Sessions Should 'Worry About His Own Problems,' Not Marijuana
U.S. Attorney General Jeff Sessions wants congressional leaders to drop a budget rider that effectively bars him from pursuing medical marijuana providers under federal anti-drug laws. California Attorney General Xavier Becerra, appearing at a Public Policy of California event Tuesday, said Sessions "should worry about his own problems before he goes after people who use marijuana for medical purposes or recreational purposes."
June 13, 2017 at 05:03 PM
14 minute read
U.S. Attorney General Jeff Sessions wants congressional leaders to drop a budget rider that effectively bars him from pursuing medical marijuana providers under federal anti-drug laws.
In his May 1 letter, Sessions called efforts to extend the “Farr-Rohrabacher” amendment “unwise.” The 2-year-old rider, a prohibition on spending Department of Justice money on prosecuting state-legal medical marijuana businesses, must be renewed with each budget cycle.
“The department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives,” Sessions wrote in the letter, first reported by the website MassRoots.
The attorney general's letter adds to the murkiness surrounding the Trump administration's position on the conflict between the 29 states and Washington, D.C., where some form of marijuana use is legal and the federal government, which still classifies marijuana as a controlled substance, illegal in all forms.
Since his tenure as a U.S. senator from Alabama, Sessions has been clear that he does not support legalization, famously telling his Senate colleagues in a 2016 hearing that “good people don't smoke marijuana.”
President Donald Trump has not been as definitive. As a candidate, he indicated several times that he supports medical marijuana and that laws governing recreational use should be left up to the states. In May, however, he issued a spending bill signing statement that said he would treat a prohibition on prosecuting state-legal medical marijuana operations “consistently with my constitutional responsibility to take care that the laws be faithfully executed.”
California Attorney General Xavier Becerra, appearing at a Public Policy of California event Tuesday, said Sessions “should worry about his own problems before he goes after people who use marijuana for medical purposes or recreational purposes.” He also predicted that Trump and Sessions won't actually crack down on medical marijuana, which enjoys widespread support in public opinion polls. “The [public] position on this is way beyond them now,” Becerra said.
We asked lawyers in the marijuana industry for their thoughts on the Sessions letter to Congress. Here are highlights, edited for length and clarity.
Steve Schain, Hoban Law Group: “It's part of the unfortunate yet predictable pattern we're seeing from U.S. Attorney General Jeff Sessions, who seems incapable of grasping the healthful and financial benefits of legalized marijuana. Although this doesn't move the panic needle further into the red, massive job and tax revenue losses will ensue if he gets his way.”
Diana Romza-Kutz, Thompson Coburn: “We need to continue to advise our clients that are in the medical marijuana industry that from a federal standpoint, they are in a precarious, what's-next position. That needs to be made clear to investors. And they need to make very, very sure that they are in strict compliance with state regulations where medical marijuana is legal.”
Hilary Bricken, Harris Bricken: “I am troubled by Attorney General Sessions' willingness to ignore the will of the American people and the facts and science regarding medical cannabis. The Rohrabacher-Farr amendment is a solid piece of bipartisan legislation that allows states to behave as laboratories of democracy—as intended by our Constitution. Though I will continue keeping an eye on the Justice Department and, in particular, what it will do with the 2013 Cole Memo, Sessions' efforts to reignite the failed war on cannabis do not keep me up at night as I still believe the government will in the end heed the views of the overwhelming majority of Americans who want to see medical cannabis legalized and protected.”
Courtney Gilligan Saleski, DLA Piper: “The tension among AG Sessions' views on marijuana, the current trajectory of liberalization of marijuana laws, and the continued federal criminalization of marijuana [even medical marijuana] was bound to come to a head with a Sessions Justice Department. We will be watching to see what Congress does, but it is hard to imagine that the amendment will, in fact, be dropped in the current medical marijuana climate. We will also have to see whether the DOJ turns away from its Obama-era guidance and starts prosecuting marijuana crimes more aggressively again.”
Marc Zilversmit, defense attorney, San Francisco Bay Area: “Under the McIntosh decision, the Rohrabacher-Farr amendment only protects medical marijuana, and only protects cultivators, dispensaries and users that are in compliance with state law. AG Loretta Lynch also sent a letter and lobbied Congress to eliminate the Rohrabacher-Farr amendment, and her efforts failed. There is no indication that AG Sessions will be any more successful. Sessions' letter is inconsistent with his long-standing support for states' rights.”
Copyright The Recorder. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Related Articles:
|- Six Key Updates in California's Latest Marijuana Regulatory Proposal
- California Prepares to Ramp Up Push for Marijuana Rules
- ​Trump's Pick for AG Worries Marijuana Advocates
- California Treasurer Seeks Marijuana Guidance From Trump, Congress
- California Regulators Want to Open Doors for Marijuana Tax Payments
U.S. Attorney General Jeff Sessions wants congressional leaders to drop a budget rider that effectively bars him from pursuing medical marijuana providers under federal anti-drug laws.
In his May 1 letter, Sessions called efforts to extend the “Farr-Rohrabacher” amendment “unwise.” The 2-year-old rider, a prohibition on spending Department of Justice money on prosecuting state-legal medical marijuana businesses, must be renewed with each budget cycle.
“The department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives,” Sessions wrote in the letter, first reported by the website MassRoots.
The attorney general's letter adds to the murkiness surrounding the Trump administration's position on the conflict between the 29 states and Washington, D.C., where some form of marijuana use is legal and the federal government, which still classifies marijuana as a controlled substance, illegal in all forms.
Since his tenure as a U.S. senator from Alabama, Sessions has been clear that he does not support legalization, famously telling his Senate colleagues in a 2016 hearing that “good people don't smoke marijuana.”
President Donald Trump has not been as definitive. As a candidate, he indicated several times that he supports medical marijuana and that laws governing recreational use should be left up to the states. In May, however, he issued a spending bill signing statement that said he would treat a prohibition on prosecuting state-legal medical marijuana operations “consistently with my constitutional responsibility to take care that the laws be faithfully executed.”
California Attorney General Xavier Becerra, appearing at a Public Policy of California event Tuesday, said Sessions “should worry about his own problems before he goes after people who use marijuana for medical purposes or recreational purposes.” He also predicted that Trump and Sessions won't actually crack down on medical marijuana, which enjoys widespread support in public opinion polls. “The [public] position on this is way beyond them now,” Becerra said.
We asked lawyers in the marijuana industry for their thoughts on the Sessions letter to Congress. Here are highlights, edited for length and clarity.
Steve Schain, Hoban Law Group: “It's part of the unfortunate yet predictable pattern we're seeing from U.S. Attorney General Jeff Sessions, who seems incapable of grasping the healthful and financial benefits of legalized marijuana. Although this doesn't move the panic needle further into the red, massive job and tax revenue losses will ensue if he gets his way.”
Diana Romza-Kutz,
Hilary Bricken, Harris Bricken: “I am troubled by Attorney General Sessions' willingness to ignore the will of the American people and the facts and science regarding medical cannabis. The Rohrabacher-Farr amendment is a solid piece of bipartisan legislation that allows states to behave as laboratories of democracy—as intended by our Constitution. Though I will continue keeping an eye on the Justice Department and, in particular, what it will do with the 2013 Cole Memo, Sessions' efforts to reignite the failed war on cannabis do not keep me up at night as I still believe the government will in the end heed the views of the overwhelming majority of Americans who want to see medical cannabis legalized and protected.”
Courtney Gilligan Saleski,
Marc Zilversmit, defense attorney, San Francisco Bay Area: “Under the McIntosh decision, the Rohrabacher-Farr amendment only protects medical marijuana, and only protects cultivators, dispensaries and users that are in compliance with state law. AG Loretta Lynch also sent a letter and lobbied Congress to eliminate the Rohrabacher-Farr amendment, and her efforts failed. There is no indication that AG Sessions will be any more successful. Sessions' letter is inconsistent with his long-standing support for states' rights.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllA Judge Asks: Is It Time to End Ken Feinberg's Roundup Settlement Program?
7 minute readWhy the Wide Range of Roundup Verdicts? It Might Depend on What Juries Hear About the EPA
8 minute readTrending Stories
- 1Commission Confirms Three of Newsom's Appellate Court Picks
- 2Judge Grants Special Counsel's Motion, Dismisses Criminal Case Against Trump Without Prejudice
- 3GEICO, Travelers to Pay NY $11.3M for Cybersecurity Breaches
- 4'Professional Misconduct': Maryland Supreme Court Disbars 86-Year-Old Attorney
- 5Capital Markets Partners Expect IPO Resurgence During Trump Administration
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250